Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 16-May-24 7:23 PM View:  | Collegium Pharmaceutical, Inc (COLL) | 16-May-24 | Grant | 7,693 | -- | -- | 18% 41.67K to 49.37K | |
| 19-May-23 4:40 PM View: | Collegium Pharmaceutical, Inc (COLL) | 18-May-23 | Grant | 9,792 | -- | -- | 31% 31.88K to 41.67K | |
| 23-May-22 4:44 PM View: | Collegium Pharmaceutical, Inc (COLL) | 19-May-22 | Grant | 14,035 | -- | -- | 79% 17.84K to 31.88K | |
| 08-Apr-22 5:12 PM View: | Collegium Pharmaceutical, Inc (COLL) | 06-Apr-22 | Grant | 17,845 | -- | -- | 100% 0 to 17.84K | |
| 24-Nov-21 4:10 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 24-Nov-21 | Grant | 75,000 | -- | -- | 14% 525.0K to 600.0K | |
| 24-Nov-21 4:10 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 24-Nov-21 | Disposition (change in control) | 600,000 | -- | -- | (100%) 600.0K to 0 | |
| 03-Mar-21 5:01 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 02-Mar-21 | Grant | 300,000 | -- | -- | 133% 225.0K to 525.0K | |
| 20-Mar-20 6:07 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 18-Mar-20 | Grant | 100,000 | -- | -- | 80% 125.0K to 225.0K | |
| 17-Sep-19 7:00 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 16-Sep-19 | Grant | 125,000 | -- | -- | 100% 0 to 125.0K | |
| 16-May-19 9:37 PM View: | Travere Therapeutics, Inc. (TVTX) | 16-May-19 | Market Sale (Planned) | 984 | $18.71 | $18,410.60 | (4%) 27.97K to 26.99K | < 1% |
| 16-May-19 9:37 PM View: | Travere Therapeutics, Inc. (TVTX) | 15-May-19 | Market Sale (Planned) | 984 | $17.78 | $17,495.50 | (3%) 28.96K to 27.97K | (4%) |
| 21-Dec-18 8:21 PM View: | Travere Therapeutics, Inc. (TVTX) | 20-Dec-18 | Market Sale (Planned) | 11,125 | $22.32 | $248,333.00 | (28%) 40.08K to 28.96K | (11%) |
| 20-Dec-18 7:57 PM View: | Travere Therapeutics, Inc. (TVTX) | 18-Dec-18 | Grant | 11,125 | -- | -- | 38% 28.96K to 40.08K | |
| 16-Nov-18 7:19 PM View: | Travere Therapeutics, Inc. (TVTX) | 14-Nov-18 | Market Sale (Planned) | 10,000 | $23.73 | $237,314.00 | (26%) 38.48K to 28.48K | (5%) |
| 14-Nov-18 8:44 PM View: | Travere Therapeutics, Inc. (TVTX) | 09-Nov-18 | Grant | 10,000 | -- | -- | 35% 28.48K to 38.48K | |
| 14-May-18 7:33 PM View: | Travere Therapeutics, Inc. (TVTX) | 10-May-18 | Grant | 10,500 | -- | -- | 60% 17.45K to 27.95K | |
| 12-Feb-18 8:38 PM View: | Travere Therapeutics, Inc. (TVTX) | 08-Feb-18 | Grant | 2,546 | -- | -- | 17% 14.9K to 17.45K | |
| 17-Aug-17 8:36 PM View: | Travere Therapeutics, Inc. (TVTX) | 16-Aug-17 | Market Sale | 1,378 | $22.50 | $31,005.00 | (9%) 15.0K to 13.62K | |
| 15-Aug-16 4:39 PM View: | Travere Therapeutics, Inc. (TVTX) | 15-Aug-16 | Grant | 15,000 | -- | -- | 100% 0 to 15.0K |